Evidence map›Paper›PMID 23585941›Full record

ArticleJournal of thoracic disease2013

Analysis of antimicrobial resistance and class 1 integrons among strains from upper respiratory tract of healthy adults.

Haiyan Liu, Hai Wang, Mao Huang, Yaning Mei, Bing Gu, Rui Wu, Yiling Huang, Yi Chen, Yanling Xu, Tong Wang

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Clonal Dissemination of Pandrug-ResistantInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Integrons: past, present, and future.Microbiology and molecular biology reviews : MMBR · 2014
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haiyan LiuDepartment of Respiratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; ; Department of Respiratory Medicine, People's Hospital of Fuyang City, Fuyang 236003, China;
Hai Wang
Mao Huang
Yaning Mei
Bing Gu
Rui Wu
Yiling Huang
Yi Chen
Yanling Xu
Tong Wang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe distribution and characterization of integrons among opportunistic pathogens from nasopharynx of healthy adults.

methodsA total of 1,019 nasopharyngeal samples from healthy adults were collected; bacteria were identified by API system; antibiotic susceptibility were tested by K-B method; class 1, 2 and 3 integrons were examined by degenerate primers of the genetic content of integrons were analyzed by PCR and DNA sequencing.

resultsOut of the 1,019 cases, 743 (72.9%) opportunistic pathogens were isolated. The top five commons organism identified were Coagulase-negative staphylococcus (n=404), Staphylococcus aureus (n=109), Haemophilus influenzae (n=74), Streptococcus pneumoniae (n=49) and Klebsiella pneumoniae (n=32). Eight (25.0%) isolates of K. pneumoniae produced the ESBLs. The isolated rates of S. aureus and H. influenzae were decreased with aging. 6.3% (2/32) K. pneumoniae isolates and 16.7% (1/8) Proteus isolates carried class 1 integrons. Among intI1-positive strains, sequencing analysis revealed that one of the integron positive K. pneumoniae isolates harbored gene cassette aadA5-dfrA17. Proteus isolates harbored gene cassette aadA2-dhfrXII.

conclusionsThe results stressed the need for continued surveillance of bacteria from the asymptomatic carriers.

Indexed as

Antimicrobial resistanceclass 1 integrongene cassetteshealthy adultsupper respiratory tract

Identifiers

PMID23585941
PMCPMC3621944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.